Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680144 · ClinicalTrials.gov registry record · NA
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03680144 is a NA study that has completed, run by Emory University. The registered enrollment target is 8 participants.
The verdict
NCT03680144, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial studies how well dynamic susceptibility contrast-magnetic resonance imaging (MRI) works in determining radiation necrosis and tumor progression in participants with cancer that has spread to the brain and are being treated with radiation therapy. Diagnostic procedures, such as dynamic susceptibility contrast-MRI, may improve the ability to determine indeterminate post-treatment changes seen on imaging after radiation therapy.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Dynamic Susceptibility Contrast-MRI (DSC-MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-11-28 |
| Est. Completion | 2021-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03680144
The ClinicalTrials.gov registry entry for NCT03680144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT03680144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03680144 about?
NCT03680144 is a clinical study titled "Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases". This trial studies how well dynamic susceptibility contrast-magnetic resonance imaging (MRI) works in determining radiation necrosis and tumor progression in participants with cancer that has spread to the brain and are being treated with radiation therapy. Diagnostic procedures, such as dynamic sus...
What is the current status of trial NCT03680144?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-11-28. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT03680144?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Dynamic Susceptibility Contrast-MRI (DSC-MRI) (PROCEDURE).
Who is sponsoring clinical trial NCT03680144?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.